Corporate Crime in the Pharmaceutical Industry

Last updated
Corporate Crime in the Pharmaceutical Industry
Corporate Crime in the Pharmaceutical Industry.jpg
First edition
Author John Braithwaite
Subject Corporate crime, pharmaceutical industry
Publisher Routledge
Publication date
1984
Pages448
ISBN 978-0710200495

Corporate Crime in the Pharmaceutical Industry is a 1984 book on corporate crime and the pharmaceutical industry by criminologist John Braithwaite. [1]

The author writes from the perspective of a criminologist and not from a perspective of expertise in drug law or pharmacology. [2]

Various reviewers commented on the book. [3] [4]

The author produced a follow up book 30 years later titled, Pharmaceuticals, Corporate Crime and Public Health. [5] At the release of that new book a reviewer reconsidered the 1984 book in retrospect and reported that the book's ideas were still relevant. [6]

The book is available at the Internet Archive.

Related Research Articles

<span class="mw-page-title-main">Pharmaceutical industry</span> Industry involved with discovery, development, production and marketing of drugs

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients, with the aim to cure them, vaccinate them, or alleviate symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices. They are subject to a variety of laws and regulations that govern the patenting, testing, safety, efficacy using drug testing and marketing of drugs. The global pharmaceuticals market produced treatments worth $1,228.45 billion in 2020 and showed a compound annual growth rate (CAGR) of 1.8%.

<span class="mw-page-title-main">David Healy (psychiatrist)</span>

David Healy, a professor of psychiatry at Bangor University in the United Kingdom, is a psychiatrist, psychopharmacologist, scientist and author. His main areas of research are the contribution of antidepressants to suicide, conflict of interest between pharmaceutical companies and academic medicine, and the history of pharmacology. Healy has written more than 150 peer-reviewed articles, 200 other articles, and 20 books, including The Antidepressant Era, The Creation of Psychopharmacology, The Psychopharmacologists Volumes 1–3, Let Them Eat Prozac and Mania: A Short History of Bipolar Disorder.

<span class="mw-page-title-main">Alosetron</span> Medication

Alosetron, sold under the brand name Lotronex among others, is a 5-HT3 antagonist used for the management of severe diarrhea-predominant irritable bowel syndrome (IBS) in women only.

Medicalization is the process by which human conditions and problems come to be defined and treated as medical conditions, and thus become the subject of medical study, diagnosis, prevention, or treatment. Medicalization can be driven by new evidence or hypotheses about conditions; by changing social attitudes or economic considerations; or by the development of new medications or treatments.

<span class="mw-page-title-main">Feminist school of criminology</span> School of criminology

The feminist school of criminology is a school of criminology developed in the late 1960s and into the 1970s as a reaction to the general disregard and discrimination of women in the traditional study of crime. It is the view of the feminist school of criminology that a majority of criminological theories were developed through studies on male subjects and focused on male criminality, and that criminologists often would "add women and stir" rather than develop separate theories on female criminality.

<i>Big Pharma</i> (book) 2006 book by Jacky Law

Big Pharma: How the World's Biggest Drug Companies Control Illness is a 2006 book by British journalist Jacky Law. The book examines how major pharmaceutical companies determine which health care problems are publicised and researched.

Jock Young was a British sociologist and an influential criminologist.

<span class="mw-page-title-main">Peter C. Gøtzsche</span> Danish physician and medical researcher (born 1949)

Peter Christian Gøtzsche is a Danish physician, medical researcher, and former leader of the Nordic Cochrane Center at Rigshospitalet in Copenhagen, Denmark. He is a co-founder of the Cochrane Collaboration and has written numerous reviews for the organization. His membership in Cochrane was terminated by its Governing Board of Trustees on 25 September 2018.

John Braithwaite is a Distinguished Professor at the Australian National University (ANU). Braithwaite is the recipient of a number of international awards and prizes for his work, including an honorary doctorate at KU Leuven (2008), the University of Louisville Grawemeyer Award with Peter Drahos for Ideas Improving World Order (2004), and the Prix Emile Durkheim, International Society of Criminology, for lifetime contributions to criminology (2005).

Funding bias, also known as sponsorship bias, funding outcome bias, funding publication bias, and funding effect, refers to the tendency of a scientific study to support the interests of the study's financial sponsor. This phenomenon is recognized sufficiently that researchers undertake studies to examine bias in past published studies. Funding bias has been associated, in particular, with research into chemical toxicity, tobacco, and pharmaceutical drugs. It is an instance of experimenter's bias.

<span class="mw-page-title-main">Jeffrey Braithwaite</span>

Jeffrey Braithwaite BA [UNE], DipIR, MIR [Syd], MBA [Macq], PhD [UNSW], FIML, FACHSM, FAAHMS, FFPHRCP [UK], FAcSS [UK], Hon FRACMA is an Australian professor, health services and systems researcher, writer and commentator. He is Founding Director of the Australian Institute of Health Innovation at Macquarie University, Sydney, Australia; Director of the Centre for Healthcare Resilience and Implementation Science, Australian Institute of Health Innovation; Professor of Health Systems Research, Macquarie University; Professor, Centre for Implementation of Hearing Research, Macquarie University.

<span class="mw-page-title-main">Criminology</span> The study of crime and criminal actions/behavior

Criminology is the study of crime and deviant behaviour. Criminology is an interdisciplinary field in both the behavioural and social sciences, which draws primarily upon the research of sociologists, political scientists, economists, psychologists, philosophers, psychiatrists, social workers, biologists, social anthropologists, as well as scholars of law.

<i>Selling Sickness</i>

Selling Sickness: How the World's Biggest Pharmaceutical Companies are Turning us All into Patients is a 2005 book by Ray Moynihan and Alan Cassels about unnecessary health care.

Green criminology is a branch of criminology that involves the study of harms and crimes against the environment broadly conceived, including the study of environmental law and policy, the study of corporate crimes against the environment, and environmental justice from a criminological perspective.

<i>The Dose Makes the Poison</i>

The Dose That Makes the Poison: A Plain Language Guide to Toxicology is a book originally written by M. Alice Ottoboni and published in 1984 by Vincente Books to help laypeople understand what she considered to be an unfounded fear of synthetic chemicals. A second edition was published in 1991 and a third, revised by Patricia Frank, was released in 2011.

<span class="mw-page-title-main">Medical–industrial complex</span>

The medical–industrial complex is a network of interactions between pharmaceutical corporations, health care personnel, and medical conglomerates to supply health care-related products and services for a profit. The term is a product of the Military–industrial complex and builds from the basis of that concept.

Joseph Gavin Collier is a British retired clinical pharmacologist and emeritus professor of medicines policy at St George's Hospital and Medical School in London, whose early research included establishing the effect of aspirin on human prostaglandins and looking at the role of nitric oxide and angiotensin converting enzyme in controlling blood vessel tone and blood pressure. Later, in his national policy work, he helped change the way drugs are priced and bought by the NHS, and ensured that members of governmental advisory committees published their conflicts of interest.

<span class="mw-page-title-main">Conflicts of interest in academic publishing</span> Overview of conflicts of interest in academic publishing

Conflicts of interest (COIs) often arise in academic publishing. Such conflicts may cause wrongdoing and make it more likely. Ethical standards in academic publishing exist to avoid and deal with conflicts of interest, and the field continues to develop new standards. Standards vary between journals and are unevenly applied. According to the International Committee of Medical Journal Editors, "[a]uthors have a responsibility to evaluate the integrity, history, practices and reputation of the journals to which they submit manuscripts".

<span class="mw-page-title-main">Public criminology</span> Academic tendency within criminology

Public criminology is an approach to criminology that disseminates criminological research beyond academia to broader audiences, such as criminal justice practitioners and the general public. Public criminology is closely tied with “public sociology”, and draws on a long line of intellectuals engaging in public interventions related to crime and justice. Some forms of public criminology are conducted through methods such as classroom education, academic conferences, public lectures, “news-making criminology”, government hearings, newspapers, radio and television broadcasting and press releases. Advocates of public criminology argue that the energies of criminologists should be directed towards "conducting and disseminating research on crime, law, and deviance in dialogue with affected communities." Public criminologists focus on reshaping the image of the criminal and work with communities to find answers to pressing questions. Proponents of public criminology see it as potentially narrowing "the yawning gap between public perceptions and the best available scientific evidence on issues of public concern", a problem they see as especially pertinent to matters of crime and punishment.

<span class="mw-page-title-main">Marshall B. Clinard</span> American sociologist who specialized in criminology

Marshall Barron Clinard was an American sociologist who specialized in criminology. Criminological studies spanned across his entire career, from an examination of the Black Market during World War II to much more general treatments of white collar crime. His 1957 textbook Sociology of Deviant Behavior is now in its 15th edition. In addition to studies within the United States, Clinard did research in Sweden, India, Uganda and Switzerland: supported, respectively, by the Fulbright Program, the Ford Foundation, the Rockefeller Foundation and the U. S. National Science Foundation.

References

  1. Braithwaite, John (1983). Corporate crime in the pharmaceutical industry (1. publ. ed.). London: Routledge & Kegan Paul. ISBN   978-0710200495.
  2. Turner, Paul (July 1986). "Corporate Crime in the Pharmaceutical Industry". International Clinical Psychopharmacology . 1 (3): 267. doi:10.1097/00004850-198607000-00011.
  3. Parker, J. (1 June 1984). "Book Reviews: Corporate Crime in the Pharmaceutical Industry by John Braithwaite. Published by Routledge & Kegan Paul, Henleyon-Thames, 1984. Pp 440. Price  25 Hardback". The Journal of the Royal Society for the Promotion of Health . 104 (3): 119. doi:10.1177/146642408410400313. S2CID   56651523.
  4. Hopkins, A. (1 September 1984). "Book Review: Corporate Crime in the Pharmaceutical Industry". Australian & New Zealand Journal of Criminology . 17 (3): 190–191. doi:10.1177/000486588401700313. S2CID   144772367.
  5. "John Braithwaite on Corporate Crime in the Pharmaceutical Industry - Corporate Crime Reporter". Corporate Crime Reporter. 23 July 2014. Retrieved 9 May 2017.
  6. Davis, C.; Abraham, J. (6 February 2013). "Is there a cure for corporate crime in the drug industry?". BMJ. 346 (feb06 1): f755. doi:10.1136/bmj.f755. PMID   23390241. S2CID   11584399.